Olanzapine for Acute Headaches

Summary

Olanzapine for Acute Headaches is a clinical trial^[1].

Key Facts

• Olanzapine for Acute Headaches is in the country of United States^[2].
• Olanzapine for Acute Headaches's instance of is recorded as clinical trial^[3].
• Olanzapine for Acute Headaches's start time is recorded as +2016-07-31T00:00:00Z^[4].
• Olanzapine for Acute Headaches's end time is recorded as +2018-05-17T00:00:00Z^[5].
• Olanzapine for Acute Headaches's sponsor is recorded as HealthPartners Institute for Education and Research^[6].
• Olanzapine for Acute Headaches's number of participants is recorded as {'unit': '1', 'amount': '+124'}^[7].
• Olanzapine for Acute Headaches's title is recorded as Oral Rapidly Dissolving Olanzapine for Acute Primary Headache in the Emergency Department Setting: A Feasibility Trial^[8].
• Olanzapine for Acute Headaches's short name is recorded as Olanzapine^[9].
• Olanzapine for Acute Headaches's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Olanzapine for Acute Headaches's ClinicalTrials.gov ID is recorded as NCT03066622^[11].
• Olanzapine for Acute Headaches's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[12].
• Olanzapine for Acute Headaches's research intervention is recorded as olanzapine^[13].
• Olanzapine for Acute Headaches's clinical trial phase is recorded as phase IV clinical trial^[14].
• Olanzapine for Acute Headaches's research subject recruitment status is recorded as completed^[15].
• Olanzapine for Acute Headaches's study type is recorded as interventional study^[16].